Clinical trial
Epigenetic Health Benefits of Budesonide
NCT04342039 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Epigenetic Health Benefits of Budesonide
- Lead sponsor
- University of British Columbia
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- January 7, 2021
- Completion date
- December 31, 2027
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
environmental exposure, epigenetic effects of intranasal steroids